Ocular surface disease is a common comorbidity of glaucoma. The management of dry eye in glaucoma presents a unique challenge to eye care practitioners, as IOP-lowering drops have extensive mechanisms for causing or exacerbating damage to the ocular surface. Here, we discuss specific mechanisms involved and ocular surface friendly tips for glaucoma management. 

Over 1300 attended our event and we received amazing feedback!

• Fantastic talk today. We are making our asymptomatic patients symptomatic. So many clever strategies. Thank you, Dr. Abbott!

• Very much enjoyed this subject and this speaker.

• Needed the glaucoma CE, but left with so much more information than I expected. Kaleb was excellent!

• Excellent speaker with very practical and helpful material.

• Have Dr. Abbott more often.

• Top notch CE as always. Thank you!

• Thanks for the typewritten handouts.

• Really excellent lecturer and presentation and I learned something new about punctal stenosis!

• Great topic and speaker. Appreciate all the information provided.

• The presentation and slides were very easy to follow!

• Enjoyed the subject and the speaker.

• Always exceeding my expectations.

• This was such a great talk! Great speaker and very helpful info! Thank you!

• Great speaker! Enjoyed the talk.

Speaker: Kaleb Abbott, OD, MS, FAAO, FOWNS

Moderator: Dr. Carolyn Majcher

COPE ID: 106774-GL

Category: Glaucoma

This event is COPE approved for 1 hour CE credit.

Thank you to Thea for exhibiting at this event.

Established in 2019, Thea Pharma is the United States subsidiary of Laboratoires Théa, a global leader and pioneer in ophthalmics. We are committed to serve doctors that treat the anterior segment and ocular surface conditions.